Samsung Biologics Co Ltd (207940) — Financial Flexibility Index
Samsung Biologics Co Ltd (207940) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of ₩733.11 Billion (operating CF ₩619.30 Billion minus capex ₩113.81 Billion) represents 0% of total liabilities (₩6.16 Trillion). Also explore 207940 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Samsung Biologics Co Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Samsung Biologics Co Ltd across 11 annual periods. Check asset allocation strategy of Samsung Biologics Co Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Samsung Biologics Co Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Samsung Biologics Co Ltd. For the full company profile including market capitalisation, see Samsung Biologics Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.47x | ₩3.04 Trillion | ₩1.66 Trillion | ₩6.43 Trillion | ▲ +5.9% |
| 2023 | 0.45x | ₩2.77 Trillion | ₩1.67 Trillion | ₩6.22 Trillion | ▲ +77.4% |
| 2022 | 0.25x | ₩1.91 Trillion | ₩953.05 Billion | ₩7.60 Trillion | ▼ -13.0% |
| 2021 | 0.29x | ₩860.85 Billion | ₩454.60 Billion | ₩2.98 Trillion | ▲ +54.4% |
| 2020 | 0.19x | ₩341.75 Billion | ₩202.09 Billion | ₩1.83 Trillion | ▲ +43.6% |
| 2019 | 0.13x | ₩202.99 Billion | ₩10.15 Billion | ₩1.56 Trillion | ▼ -3.1% |
| 2018 | 0.13x | ₩245.63 Billion | ₩-33.02 Billion | ₩1.82 Trillion | ▼ -33.0% |
| 2017 | 0.20x | ₩643.94 Billion | ₩149.82 Billion | ₩3.21 Trillion | ▲ +556.7% |
| 2016 | 0.03x | ₩105.51 Billion | ₩-62.66 Billion | ₩3.45 Trillion | ▲ +486.7% |
| 2015 | -0.01x | ₩-25.19 Billion | ₩-265.51 Billion | ₩3.19 Trillion | ▼ -102.2% |
| 2014 | 0.36x | ₩257.63 Billion | ₩-108.30 Billion | ₩724.97 Billion | — |